Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Isoleucyl-tRNA Synthetase (IARS) (Middle Region) Peptide

IARS Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN978371
  • Target See all IARS products
    IARS (Isoleucyl-tRNA Synthetase (IARS))
    Protein Region
    Middle Region
    Origin
    Human
    Source
    • 3
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Sequence
    YEAAKVFGLR SRKLKLFLNE TQTQEITEDI PVKTLNMKTV YVSVLPTTAD
    Characteristics
    This is a synthetic peptide designed for use in combination with anti-IARS Antibody(ARP54954_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Application Notes
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handling Advice
    Avoid repeated freeze-thaw cycles.
    Storage
    -20 °C
    Storage Comment
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    IARS (Isoleucyl-tRNA Synthetase (IARS))
    Synonyms
    fi46h05 Peptide, zgc:63790 Peptide, wu:fi46h05 Peptide, K19E20.18 Peptide, K19E20_18 Peptide, ovule abortion 2 Peptide, ECK0027 Peptide, ilvS Peptide, JW0024 Peptide, An08g06770 Peptide, AO090012000505 Peptide, 2510016L12Rik Peptide, AI327140 Peptide, AU044614 Peptide, E430001P04Rik Peptide, ILRS Peptide, Iarsl Peptide, IARS1 Peptide, ILERS Peptide, IRS Peptide, PRO0785 Peptide, isoleucyl-tRNA synthetase Peptide, tRNA synthetase class I (I, L, M and V) family protein Peptide, isoleucine--tRNA ligase Peptide, isoleucyl-tRNA synthetase, cytoplasmic Peptide, isoleucine-tRNA synthetase Peptide, iars Peptide, IARS Peptide, OVA2 Peptide, ileS Peptide, MBAR_RS19160 Peptide, Rmag_0340 Peptide, ANI_1_964074 Peptide, CHLREDRAFT_106327 Peptide, EDI_049880 Peptide, OE_RS08520 Peptide, AOR_1_1912194 Peptide, Iars Peptide
    Background
    Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAS, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Isoleucine-tRNA synthetase belongs to the class-I aminoacyl-tRNA synthetase family and has been identified as a target of autoantibodies in the autoimmune disease polymyositis/dermatomyositis. Two alternatively spliced variants have been isolated that represent alternate 5' UTRs.

    Alias Symbols: FLJ20736, IARS1, ILRS, PRO0785, IRS, ILERS

    Protein Interaction Partner: AR,EPRS,GARS,AIMP2,AKTIP,BCAR3,EPRS,GARS,GSTK1,MAGED1,MCC,SGK1,SNCA,TRAF6,TSC22D1,USP19,VHL

    Protein Size: 1262
    Molecular Weight
    144 kDa
    Gene ID
    3376
    NCBI Accession
    NM_013417, NP_038203
    UniProt
    P41252
You are here:
Support